InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,434.43
(
1.68%
)
US TECH 100
18,514.00
(
2.54%
)
Dow Jones
39,765.64
(
1.04%
)
Brent Oil
80.41
(
-1.46%
)
Bitcoin
60,672.74
(
2.22%
)
Post# of 252873
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

alertmeipp

Send PM Follow Ignore
Followers 13
Posts 2701
Boards Moderated 0
Alias Born 07/18/2006

alertmeipp

Re: Katsche post# 104948

Friday, 09/24/2010 9:26:45 AM

Friday, September 24, 2010 9:26:45 AM

Post# of 252873
Teva is in a dilemma, on one hand, they doesn't want lower FDA's generic approval requirement because it may hurts its Capoxane .
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up